GPC3 and Simpson-Golabi-Behmel syndrome: The human GPC3 gene was first identified in 1996 in patients with Simpson–Golabi–Behmel syndrome (SGBS), and its mutations are strongly implicated in the syndrome’s pathogenesis [2].